$HAE stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $49,478,246 of trading volume.
It has been the 767th most-searched ticker on Quiver Quantitative over the last day, out of 10,816 total tickers searched.
Here is what we see in our data on $HAE (you can track the company live on Quiver's $HAE stock page):
$HAE Insider Trading Activity
$HAE insiders have traded $HAE stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HAE stock by insiders over the last 6 months:
- MARK W KROLL purchased 1,400 shares for an estimated $98,784
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HAE Hedge Fund Activity
We have seen 158 institutional investors add shares of $HAE stock to their portfolio, and 174 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 1,829,150 shares (-85.2%) from their portfolio in Q3 2025, for an estimated $89,152,771
- AQR CAPITAL MANAGEMENT LLC added 1,678,630 shares (+372.8%) to their portfolio in Q3 2025, for an estimated $81,816,426
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,139,043 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $55,516,955
- UBS GROUP AG removed 912,894 shares (-62.8%) from their portfolio in Q4 2025, for an estimated $73,168,454
- SG CAPITAL MANAGEMENT LLC removed 906,892 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $44,201,916
- MILLENNIUM MANAGEMENT LLC added 735,592 shares (+1957.0%) to their portfolio in Q3 2025, for an estimated $35,852,754
- VICTORY CAPITAL MANAGEMENT INC removed 707,833 shares (-90.9%) from their portfolio in Q3 2025, for an estimated $34,499,780
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HAE Government Contracts
We have seen $82,487 of award payments to $HAE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BLOOD ADDITIVE SOLUTION FOR NAVAL HOSPITAL GUAM: $23,519
- EXPRESS REPORT: EXPRESS REPORT: NX ORDERS PLACED DURING THE MONTHS OF JAN-MAY 2025.: $22,660
- (R) HAEMONETICS CORPORATION:1177264 [25-002935] AUTOMATED CELL PROCESSORS ACP 215 SERIAL NUMBER 19C027SPG ...: $12,166
- TEG ANALYZERS: $8,148
- HAEMONETICS CORPORATION:1177264 [24-006940]: $8,148
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$HAE Analyst Ratings
Wall Street analysts have issued reports on $HAE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/06/2026
- Mizuho issued a "Outperform" rating on 12/17/2025
- Barrington Research issued a "Outperform" rating on 11/07/2025
- Raymond James issued a "Outperform" rating on 08/11/2025
To track analyst ratings and price targets for $HAE, check out Quiver Quantitative's $HAE forecast page.
$HAE Price Targets
Multiple analysts have issued price targets for $HAE recently. We have seen 8 analysts offer price targets for $HAE in the last 6 months, with a median target of $84.0.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $88.0 on 02/06/2026
- Michael Petusky from Barrington Research set a target price of $94.0 on 02/06/2026
- Anthony Petrone from Mizuho set a target price of $80.0 on 02/06/2026
- David Rescott from Baird set a target price of $99.0 on 12/15/2025
- Rohin Patel from JP Morgan set a target price of $74.0 on 12/12/2025
- Joanne Wuensch from Citigroup set a target price of $88.0 on 12/11/2025
- Mike Matson from Needham set a target price of $78.0 on 11/07/2025
You can track data on $HAE on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
